← FDA Drug Approvals (Drugs@FDA)

SUCRALFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABON PHARMS LLC · Approved 2024-03-21

Drug application

FDA Application #

ANDA216726

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUCRALFATE

Generic name

SUCRALFATE

Active ingredients

SUCRALFATE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

ABON PHARMS LLC

Manufacturer

Ingenus Pharmaceuticals, LLC

First approval

2024-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown